SPECTRAL MEDICAL
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device … Read more
Market Cap & Net Worth: SPECTRAL MEDICAL (SD4)
SPECTRAL MEDICAL (F:SD4) has a market capitalization of $238.92 Million (€232.76 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #15935 globally and #1644 in its home market, demonstrating a -4.17% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SPECTRAL MEDICAL's stock price €0.81 by its total outstanding shares 289138820 (289.14 Million).
SPECTRAL MEDICAL Market Cap History: 2015 to 2026
SPECTRAL MEDICAL's market capitalization history from 2015 to 2026. Data shows growth from $146.02 Million to $238.92 Million (4.82% CAGR).
SPECTRAL MEDICAL Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SPECTRAL MEDICAL's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SD4 by Market Capitalization
Companies near SPECTRAL MEDICAL in the global market cap rankings as of March 18, 2026.
Key companies related to SPECTRAL MEDICAL by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
SPECTRAL MEDICAL Historical Marketcap From 2015 to 2026
Between 2015 and today, SPECTRAL MEDICAL's market cap moved from $146.02 Million to $ 238.92 Million, with a yearly change of 4.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €238.92 Million | +1.26% |
| 2025 | €235.95 Million | +148.44% |
| 2024 | €94.97 Million | +15.11% |
| 2023 | €82.51 Million | +12.10% |
| 2022 | €73.60 Million | +69.86% |
| 2021 | €43.33 Million | -45.93% |
| 2020 | €80.13 Million | -41.56% |
| 2019 | €137.12 Million | +176.65% |
| 2018 | €49.56 Million | -28.33% |
| 2017 | €69.15 Million | +29.44% |
| 2016 | €53.42 Million | -63.41% |
| 2015 | €146.02 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of SPECTRAL MEDICAL was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $238.92 Million USD |
| MoneyControl | $238.92 Million USD |
| MarketWatch | $238.92 Million USD |
| marketcap.company | $238.92 Million USD |
| Reuters | $238.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.